celecoxib has been researched along with trinitrobenzenesulfonic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, XY; Lu, YM; Zhang, L | 1 |
| Dong, Xy; Lv, Ym; Ye, Sm; Zhang, L | 1 |
| Brzozowski, T; Drozdowicz, D; Karczewska, E; Konturek, SJ; Krzysiek-Maczka, G; Pajdo, R; Pawlik, WW; Ptak-Belowska, A; Sliwowski, Z; Urbanczyk, K; Zwolinska-Wcislo, M | 1 |
| Hong, S; Jung, Y; Kim, W; Lee, Y; Park, H; Yoon, JH; Yum, S | 1 |
4 other study(ies) available for celecoxib and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Effects and mechanism of the selective COX-2 inhibitor, celecoxib, on rat colitis induced by trinitrobenzene sulfonic acid.
Topics: Animals; Celecoxib; Colitis; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Inflammation; Intestinal Mucosa; Male; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Trinitrobenzenesulfonic Acid | 2004 |
[Mechanism of exacerbation of colonic damage in experimental colitis treated with celecoxib].
Topics: Animals; Celecoxib; Colitis; Colon; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Male; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Sulfonamides; Trinitrobenzenesulfonic Acid | 2008 |
Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Load; Bacterial Translocation; Celecoxib; Chemokines; Colitis; Colon; Cyclooxygenase 2 Inhibitors; Enterococcus; Escherichia coli; Feces; Humans; Intestinal Mucosa; Intestines; Male; Microcirculation; Peroxidase; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Trinitrobenzenesulfonic Acid | 2011 |
Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: a potential pharmacologic mechanism and therapeutic advantages.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cell Line; Colitis; Colon; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation; Humans; Male; Mice; Prodrugs; Pyrazoles; Rats; Sulfonamides; Trinitrobenzenesulfonic Acid | 2014 |